Posterior capsule opacification. Part 1: Experimental investigations

Area of Science:

• Ophthalmology
• Cell Biology
• Biotechnology

Background:

• Posterior capsule opacification (PCO) is the most frequent complication impacting vision post-cataract surgery.
• Existing PCO prevention methods lack practicality, efficacy, and safety for routine clinical use.
• Recent advancements have introduced novel concepts and methods for PCO investigation and prevention.

Purpose of the Study:

• To review clinical and experimental investigations of PCO, focusing on developments since 1992.
• To address in vitro models for PCO research, the pathophysiology and molecular biology of lens epithelial cells (LECs), and PCO prevention strategies.
• To highlight methods for culturing human LECs for in vitro modeling and investigating LEC pathophysiology.

Main Methods:

• Development of in vitro models using cultured human LECs from capsulotomy specimens.
• Investigation of the effect of lens capsule morphology (sharp bends) on LEC migration (contact inhibition).
• Application of specific inhibitors, including b-FGF-saporin immunotoxin, EDTA, and RGD-peptides, to inhibit LEC migration.

Main Results:

• Established methods for culturing human LECs, including those from intact capsular bags, for in vitro PCO research.
• Demonstrated that a sharp bend in the lens capsule can induce contact inhibition of migrating LECs.
• Showcased the efficacy of specific agents like b-FGF-saporin, EDTA, and RGD-peptides in inhibiting LEC migration.

Conclusions:

• Novel in vitro models using human LECs provide valuable tools for studying PCO pathophysiology.
• Contact inhibition and targeted molecular interventions show promise for preventing PCO.
• Further research into these methods could lead to improved clinical strategies for PCO prevention.